Evidence implicating peroxisome proliferator-activated receptor-? in the pathogenesis of preeclampsia

Hypertension

Volumn 58, Issue 5, 2011, Pages 882-887

  McCarthy, Fergus P ^a   Drewlo, Sascha ^c   English, Fred A ^a   Kingdom, John ^c   Johns, Edward J ^b   Kenny, Louise C ^a   Walsh, Sarah K ^a  

^a Anu Research Centre   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Peroxisome proliferator activated receptor ; Preeclampsia; T0070907; Vascular dysfunction

Indexed keywords

2 CHLORO 5 NITRO N (4 PYRIDYL)BENZAMIDE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; GESTATIONAL AGE; MEAN ARTERIAL PRESSURE; NEONATAL WEIGHT LOSS; NONHUMAN; PATHOGENESIS; PLACENTA; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; RAT; THROMBOCYTE AGGREGATION; TROPHOBLAST;

ANIMALS; BIOPSY, NEEDLE; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOHISTOCHEMISTRY; PLATELET AGGREGATION; PPAR GAMMA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY, ANIMAL; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; REFERENCE VALUES; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; URINALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 83155175246     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.179440     Document Type: Article

References (31)

1. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376:631-644.
2. Redman CW, Sargent IL. Placental stress and pre-eclampsia: a revised view. Placenta. 2009;30(suppl A):S38-S42.
3. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM. The nuclear receptor superfamily: the second decade. Cell. 1995;83:835-839.
4. Cipolla MJ, Bishop N, Vinke RS, Godfrey JA. PPAR{gamma} activation prevents hypertensive remodeling of cerebral arteries and improves vascular function in female rats. Stroke. 2010;41:1266-1270.
5. Marx N, Bourcier T, Sukhova GK, Libby P, Plutzky J. PPARy activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARy as a potential mediator in vascular disease. Arterioscler Thromb Vasc Biol. 1999;19:546-551. (Pubitemid 29135154)
6. Schaiff WT, Carlson MG, Smith SD, Levy R, Nelson DM, Sadovsky Y. Peroxisome proliferator-activated receptor-y modulates differentiation of human trophoblast in a ligand-specific manner. J Clin Endocrinol Metab. 2000;85:3874-3881.
7. Parast MM, Yu H, Ciric A, Salata MW, Davis V, Milstone DS. PPARy regulates trophoblast proliferation and promotes labyrinthine trilineage differentiation. PLoS One. 2009;4:e8055.
8. Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, Satoh S, Nakano R, Ishii C, Sugiyama T, Eto K, Tsubamoto Y, Okuno A, Murakami K, Sekihara H, Hasegawa G, Naito M, Toyoshima Y, Tanaka S, Shiota K, Kitamura T, Fujita T, Ezaki O, Aizawa S, Kadowaki T. PPAR-/mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell. 1999;4:597-609. (Pubitemid 29531139)
9. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A, Evans RM. PPAR yis required for placental, cardiac, and adipose tissue development. Mol Cell. 1999;4:585-595. (Pubitemid 29531138)
10. McCarthy FP, Drewlo S, Kingdom J, Johns EJ, Walsh SK, Kenny LC. Peroxisome proliferator-activated receptor-{gamma} as a potential therapeutic target in the treatment of preeclampsia. Hypertension. 2011;58: 280-286.
11. Waite LL, Louie RE, Taylor RN. Circulating activators of peroxisome proliferator-activated receptors are reduced in preeclamptic pregnancy. J Clin Endocrinol Metab. 2005;90:620-626. (Pubitemid 40279171)
12. Holdsworth-Carson SJ, Lim R, Mitton A, Whitehead C, Rice GE, Permezel M, Lappas M. Peroxisome proliferator-activated receptors are altered in pathologies of the human placenta: gestational diabetes mellitus, intrauterine growth restriction and preeclampsia. Placenta. 2010;31:222-229.
13. Lee G, Elwood F, McNally J, Weiszmann J, Lindstrom M, Amaral K, Nakamura M, Miao S, Cao P, Learned RM, Chen JL, Li Y. T0070907, a selective ligand for peroxisome proliferator-activated receptory, functions as an antagonist of biochemical and cellular activities. J Biol Chem. 2002;277:19649-19657. (Pubitemid 34967479)
14. Victor NA, Wanderi EW, Gamboa J, Zhao X, Aronowski J, Deininger K, Lust WD, Landreth GE, Sundararajan S. Altered PPARy expression and activation after transient focal ischemia in rats. Eur J Neurosci. 2006;24: 1653-1663. (Pubitemid 44427534)
15. Collin M, Murch O, Thiemermann C. Peroxisome proliferator-activated receptor-y antagonists GW9662 and T0070907 reduce the protective effects of lipopolysaccharide preconditioning against organ failure caused by endotoxemia. Crit Care Med. 2006;34:1131-1138.
16. Walsh SK, English FA, Johns EJ, Kenny LC. Plasma-mediated vascular dysfunction in the reduced uterine perfusion pressure model of preeclampsia: a microvascular characterization. Hypertension. 2009;54: 345-351.
17. Chambers JC, Fusi L, Malik IS, Haskard DO, De Swiet M, Kooner JS. Association of maternal endothelial dysfunction with preeclampsia. JAMA. 2001;285:1607-1612. (Pubitemid 32240253)
18. de Rijk EP, van Esch E, Flik G. Pregnancy dating in the rat: placental morphology and maternal blood parameters. Toxicol Pathol. 2002;30: 271-282. (Pubitemid 34293052)
19. Konijnenberg A, Stokkers EW, van der Post JA, Schaap MC, Boer K, Bleker OP, Sturk A. Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules. Am J Obstet Gynecol. 1997;176:461-469. (Pubitemid 27107940)
20. Forman BM, Chen J, Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors aandS. Proc Natl Acad Sci USA. 1997;94:4312-4317. (Pubitemid 27194238)
21. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649-658. (Pubitemid 36278583)
22. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672-683. (Pubitemid 38364626)
23. George EM, Cockrell K, Aranay M, Csongradi E, Stec DE, Granger JP. Induction of heme oxygenase 1 attenuates placental ischemia-induced hypertension. Hypertension. 2011;57:941-948.
24. Kronke G, Kadl A, Ikonomu E, Bluml S, Furnkranz A, Sarembock IJ, Bochkov VN, Exner M, Binder BR, Leitinger N. Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors. Arterioscler Thromb Vasc Biol. 2007;27: 1276-1282. (Pubitemid 46809415)
25. Nakamura M, Sekizawa A, Purwosunu Y, Okazaki S, Farina A, Wibowo N, Shimizu H, Okai T. Cellular mRNA expressions of anti-oxidant factors in the blood of preeclamptic women. Prenat Diagn. 2009;29:691-696.
26. Ahmed A, Rahman M, Zhang X, Acevedo CH, Nijjar S, Rushton I, Bussolati B, St John J. Induction of placental heme oxygenase-1 is protective against TNFa-induced cytotoxicity and promotes vessel relaxation. Mol Med. 2000;6:391-409.
27. Gadonski G, LaMarca BB, Sullivan E, Bennett W, Chandler D, Granger JP. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6. Hypertension. 2006;48:711-716. (Pubitemid 44843876)
28. Fournier T, Therond P, Handschuh K, Tsatsaris V, Evain-Brion D. PPARy and early human placental development. Curr Med Chem. 2008; 15:3011-3024.
29. Rauwel B, Mariame B, Martin H, Nielsen R, Allart S, Pipy B, Mandrup S, Devignes MD, Evain-Brion D, Fournier T, Davrinche C. Activation of peroxisome proliferator-activated receptor yby human cytomegalovirus for de novo replication impairs migration and invasiveness of cytotro-phoblasts from early placentas. J Virol. 2010;84:2946-2954.
30. Fournier T, Pavan L, Tarrade A, Schoonjans K, Auwerx J, Rochette-Egly C, Evain-Brion D. The role of PPAR-y/RXR-a heterodimers in the regulation of human trophoblast invasion. Ann N Y Acad Sci. 2002;973: 26-30. (Pubitemid 36124973)
31. Cudmore M, Ahmad S, Al-Ani B, Fujisawa T, Coxall H, Chudasama K, Devey LR, Wigmore SJ, Abbas A, Hewett PW, Ahmed A. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation. 2007;115:1789-1797. (Pubitemid 46648616)